HDAC9 and pancreatic neoplasm: Another novel HDAC inhibitor, CG200745 (ivaltinostat), has also demonstrated anti-tumour effects as a monotherapy or in combination with chemotherapy in various cancers including renal, colon, and pancreatic cancer [192].